Digital Pathology Market Size Is Expected To Reach USD 1.5 Billion by 2028

 Digital Pathology Market Growth & Trends

The global digital pathology market size is expected to reach USD 1.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.8% from 2021 to 2028. The increasing prevalence of chronic diseases triggers the demand for advanced diagnostics, which is expected to drive market growth. Growing economic stability and awareness pertaining to the benefits of using Computer-Aided Diagnostics (CAD) is further contributing to the growth.

Moreover, supportive regulations amidst COVID-19 pandemic is anticipated to increase penetration of digital pathology system in coming years. A March 2020 memorandum issued by the CMS stated that laboratories would be allowed to utilize temporary testing sites, such as homes, for digital pathology review and reporting, even if they are not CLIA-certified (provided that certain criteria are met). This waiver gives pathology labs the necessary regulatory flexibility to remotely maintain operations during the pandemic.

During the pandemic, interim extraordinary measures were put in place in relation to Medical Device Single Audit Program (MDSAP) audits. These allowed substitutions of on-site audits with alternative arrangements, such as desktop audit, remote audit, hybrid audit, and surrogate audit. In July 2020, Proscia received MDSAP certification.

Digital pathology has an important role in companion diagnostics and drug development pipeline, including molecular biology, biobanking, molecular tissue profiling, and tissue microarray analysis. Increasing demand for high-quality tissue samples in tissue-based biomarker research is expected to propel the adoption of the technology over the forecast period.

Request a free sample copy or view report summary: Digital Pathology Market Report

Digital Pathology Market Report Highlights

• Devices held the dominant market share in 2020 owing to increased use in academic research
• The rising implementation of slide management system in stratified medicine and tissue-based biomarker research is one of the key contributing factors for the dominance of this technology
• The software segment is expected to witness lucrative growth in the near future as the product assists in faster diagnosis and synchronization of patient data, where healthcare professionals can remotely access this information
• Digital pathology is increasingly used in academic research owing to various benefits, such as cost-effectiveness and rapid results
• The disease diagnosis segment is expected to witness lucrative growth over the forecast period owing to the increasing prevalence of cancer and demand for noble diagnosis techniques
• The availability of unified platforms for workflows in pathology is anticipated to boost the usage of computer-aided imaging technology in academic research, which is anticipated to boost segment growth
• Hospitals led the end-use segment in 2020 owing to the increasing adoption of digital pathology
• The market is expected to remain innovation-led, with frequent acquisitions and strategic alliances. New product development and well-established distribution channels are key to the competitive advantage of leading players
• An increasing usage rate of the digital imaging systems to facilitate faster diagnosis, particularly of chronic diseases; the increased uptake of these products serves as the key driver of this market

Digital Pathology Market Segmentation

Grand View Research has segmented the global digital pathology market on the basis of product, application, end-use, and region:

Digital Pathology Product Outlook (Revenue, USD Million, 2016 - 2028)

• Software
• Device
• Storage System

Digital Pathology Application Outlook (Revenue, USD Million, 2016 - 2028)

• Drug Discovery & Development
• Academic research
• Disease Diagnosis

Digital Pathology End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Biotech & pharma companies
• Diagnostic Labs
• Academic & research institutes

Digital Pathology Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Switzerland
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Indonesia
  • Thailand
  • Australia
  • South Korea
  • Philippines
  • Malaysia
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • Saudi Arabia
  • South Africa
  • Turkey
  • Iran
  • United Arab Emirates
  • Israel

List of Key Players of Digital Pathology Market

• Danaher
• Hamamatsu Photonics, Inc
• Koninklijke Philips N.V.
• Olympus Corporation
• Hoffmann-La Roche Ltd
• Mikroscan Technologies
• Inspirata, Inc
• Visiopharm A/S
• Huron Digital Pathology
• 3DHISTECH Ltd.
• ContextVision AB

Access Press Release of Digital Pathology Market @ https://www.grandviewresearch.com/press-release/global-digital-pathology-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Demand Surgical Equipment Market Increasing in Most Part of World 2028

 Surgical Equipment Market Growth & Trends

The global surgical equipment market size is anticipated to reach USD 24.5 billion by 2028 registering a CAGR of 9.8%, according to a new report by Grand View Research, Inc. Developing surgical care infrastructure, the advent of minimally invasive surgical techniques, and increasing cases of cesarean deliveries are the factors contributing significantly to the growth of this market. An increasing number of hospital visits for surgeries, such as hip and knee replacement, hernia repair, gall bladder removal, and other urology ailments, is also anticipated to propel the market growth during the forecast period.

According to the National Joint Registry report published in 2018, the number of knee replacement procedures performed in the U.K. reached 102,177 in 2017 from 81,590 in 2014. Lump-sum payment pertaining to specialty surgical services paired with out-of-pocket-based healthcare in many middle-income countries is expected to restrain the market growth during the forecast period. According to the global surgery 2030 report, each year over 33 million individuals have to face catastrophic expenditure. In addition, due to the limitation of resources, such as personal protective equipment, surgical staff, OR rooms, inpatient beds, and blood products, the surgery appointment for many non-emergent patients was postponed during the pandemic.

This has negatively impacted the sales of surgical equipment in 2020. According to the Healthcare Financial Management Association report, in the U.S. the cancellation and rescheduling rate of elective surgeries in the period of April-July 2020 was approximately 50%. However, currently, with several countries lifting bans on elective surgeries and clinics resuming their surgical services, the demand for surgical equipment, especially single-use devices, is expected to rise driving the market growth.

Request a free sample copy or view report summary: Surgical Equipment Market Report

Surgical Equipment Market Report Highlights

• The surgical sutures & staplers product segment held the largest market share in 2020 and will expand further at a steady CAGR from 2021 to 2028
• This growth is attributed to technological advancements, such as drug-eluting sutures and absorbable staples
• The electrosurgical devices segment is anticipated to register the fastest CAGR of 11.2% during the forecast period
• The obstetrics & gynecology application segment accounted for the largest revenue share in 2020
• However, plastic & reconstructive is estimated to be the fastest-growing application segment at a CAGR of 11.0% over the forecast period
• North America was the leading regional market in 2020 as the U.S. is one of the major suppliers of surgical equipment globally
• The Asia Pacific is expected to be the fastest-growing regional market over the forecast period due to high unmet surgical needs in emerging economies

Surgical Equipment Market Segmentation

Grand View Research has segmented the global surgical equipment market on the basis of product, application, and region:

Surgical Equipment Product Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Surgical Sutures & Staplers
• Handheld Surgical Devices
  • Forceps & Spatulas
  • Retractors
  • Dilators
  • Graspers
  • Auxiliary Instruments
  • Cutter Instruments
  • Others
• Electrosurgical Devices

Surgical Equipment Application Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Neurosurgery
• Plastic & Reconstructive Surgery
• Wound Closure
• Obstetrics & Gynecology
• Cardiovascular
• Orthopedic
• Others

Surgical Equipment Regional Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

List of Key Players of Surgical Equipment Market

• Smith & Nephew plc
• Zimmer Biomet Holdings, Inc.
• Braun Melsungen AG
• Medtronic PLC
• Stryker Corporation
• Ethicon, Inc.
• Aspen Surgical Products, Inc.
• Alcon Laboratories, Inc.

Access Press Release of Surgical Equipment Market @ https://www.grandviewresearch.com/press-release/global-surgical-equipment-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Clinical Trials Market Witness Excellent Revenue Growth During 2021-2028: Grand View Research Inc

 Clinical Trials Market Growth & Trends

The global clinical trials market size is expected to reach USD 69.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.7% from 2021 to 2028. An increase in the volume and complexity of clinical trials has been witnessed lately, which plays an important role in the R&D of new drugs and other products. Also, clinical studies have become increasingly costly ventures, adding to the overall cost of developing a drug. Hence, big pharmaceuticals as well as small biotechnology firms are looking for innovative ways to improve research outcomes and decrease research costs.

The increasing need to develop new therapeutics for chronic diseases such as cancer, respiratory disorder, diabetes, cardiovascular disease, and others is creating immense pressure on healthcare. The global pandemic caused due to COVID-19 and the increasing demand for developing a suitable treatment for the same is driving the market’s growth. The number of people affected by the coronavirus has reached one million, which further depicts an increasing need for therapeutics and vaccines. Currently, there are 288 therapeutics and 106 vaccines in development. Out of this, nearly 7.0% therapeutics are in Phase IV, 21.0% in Phase III, 43.0% & 13.0% in Phase II & Phase I respectively.

The pandemic has also resulted in global disruption of traditional onsite clinical studies. Hence, the regulatory bodies all over the world have launched various initiatives for fast-tracking clinical studies for the development of innovative solutions. One such instance is Solidarity, an international clinical trial launched by the WHO to find effective treatment against COVID-19.

Though COVID-19 is forcing many medical device and drug developers to revise the approach they prepare for these types of crises, integrating best practices within clinical trial procedures and adapting to virtual studies can support continuous development of therapeutics even in the presence of this pandemic.

Request a free sample copy or view report summary: Clinical Trials Market Report

Clinical Trials Market Report Highlights

• Phase III clinical trials dominated the market with a share of 53.2% in 2020. This is attributed to the complexity level associated with this phase
• Interventional design segment accounted for the largest share of 45.6% in 2020 in the study design segment owing to the increasing demand for the intervention for clinical studies by researchers
• North America held 51.0% of the market share in 2020. Favorable government initiatives and presence of large numbers of players in the U.S. offerings advanced services are responsible for market growth
• In Asia Pacific, the market is expected to witness the fastest CAGR of 6.7% over the forecast period owing to the increasing patient pool and cost efficient services

Clinical Trials Market Segmentation

Grand View Research has segmented the global clinical trials market based on phase, study design, indication, and region:

Clinical Trials Phase Outlook (Revenue, USD Million, 2016 - 2028)

• Phase I
• Phase II
• Phase III
• Phase IV

Clinical Trials Study Design Outlook (Revenue, USD Million, 2016 - 2028)

• Interventional
• Observational
• Expanded Access

Clinical Trials Indication Outlook (Revenue, USD Million, 2016 - 2028)

• Autoimmune/Inflammation
• Pain management
• Oncology
• CNS condition
• Diabetes
• Obesity
• Cardiovascular
• Others

Clinical Trials Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
• Asia Pacific
  • India
  • Japan
  • China
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Clinical Trials Market

• IQVIA
• PAREXEL International Corporation
• Pharmaceutical Product Development, LLC
• Charles River Laboratory
• ICON Plc
• PRA Health Sciences
• Syneos Health
• Eli Lilly and Company
• Novo Nordisk A/S
• Pfizer
• Clinipace

Access Press Release of Clinical Trials Market @ https://www.grandviewresearch.com/press-release/clinical-trials-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Healthcare Contract Research Organization Market will be Worth USD 66.1 Billion by 2028: Grand View Research Inc.

 Healthcare CRO Market Growth & Trends

The global healthcare contract research organization market size is expected to reach USD 66.1 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.6% from 2021 to 2028. The increasing cost of drug development is expected to drive the market over the forecast period. Moreover, rising clinical trial cost and challenges pertaining to patient recruitment have led biopharmaceutical companies to turn to regions like Central and Eastern Europe, Asia Pacific, Latin America, and the Middle East for cost savings and quick patient recruitment.

In addition, growing pressure on industry players to follow stringent timelines has increased the demand for outsourcing research activities to contract research organizations (CROs). Some government organizations are also outsourcing their clinical trial activities so that they can carry out clinical trials with the required infrastructure and expertise and minimize their cost and timelines.

However, the CRO market has been significantly impacted by the ongoing pandemic. The worldwide focus on finding a vaccine against coronavirus has had a significant impact on the development of other vaccines and drugs. At the peak of the pandemic, vaccines and treatments for COVID-19 accounted for 30% of all the trials in the U.S. This resulted in other trials being put on hold.

The CRO market is recovering slowly through a hybrid approach. They are playing a significant role in helping sponsors and sites to start clinical trials. Market players have already built powerful tools to support virtual clinical trials. They are ready to rapidly assist sponsors to shift to this new environment and leverage the available tools.

Request a free sample copy or view report summary: Healthcare CRO Market Report

Healthcare CRO Market Report Highlights

• Based on type, clinical trial services dominated the global market in 2020 and held a share of 76.7% owing to the fact that it comprises four elaborate phases, including human subjects
• By service, the clinical monitoring segment held the largest revenue share in 2020
• North America held a significant share in 2020 due to the presence of several global players, who invest a major part of their revenue in research activities
• Asia Pacific is anticipated to register the fastest CAGR over the forecast period due to the reduced cost it offers in comparison to the U.S. and other developed economies. China, Japan, and India are projected to witness tremendous growth in the contract research organization market owing to high disease prevalence

Healthcare CRO Market Segmentation

Grand View Research has segmented the global healthcare contract research organization market based on type, service, and region:

Healthcare CRO Type Outlook (Revenue, USD Million, 2016 - 2028)

• Drug Discovery
  • Target Validation
  • Lead Identification
  • Lead Optimization
• Pre-clinical
• Clinical
  • Phase I Trial Services
  • Phase II Trial Services
  • Phase III Trial Services
  • Phase IV Trial Services

Healthcare CRO Service Outlook (Revenue, USD Million, 2016 - 2028)

• Project Management/Clinical Supply Management
• Data Management
• Regulatory/Medical Affairs
• Medical Writing
• Clinical Monitoring
• Quality Management/ Assurance
• Bio-statistics
• Investigator Payments
• Laboratory
• Patient and Site Recruitment
• Technology
• Others

Healthcare CRO Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Switzerland
  • Belgium
  • Netherlands
  • Austria
• Asia Pacific
  • India
  • China
  • Japan
  • Korea (Republic)
  • Taiwan
  • Australia
  • Indonesia
  • Malaysia
  • Singapore
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Iran
  • Israel

List of Key Players of Healthcare CRO Market

• IQVIA
• Covance
• Pharmaceutical Product Development, LLC (PPD)
• PAREXEL International Corporation
• Charles River Laboratories (CRL)
• ICON plc
• Medidata Solutions
• Syneos Health
• Pharmaron
• GVK Biosciences Private Limited

Access Press Release of Healthcare Contract Research Organization Market @ https://www.grandviewresearch.com/press-release/global-healthcare-cro-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Revenue Cycle Management Market Size Is Anticipated To Reach $633.6 Billion by 2028

 

Revenue Cycle Management Market Growth & Trends

The global revenue cycle management market size is projected to reach USD 633.6 billion by 2028, according to a new report by Grand View Research, Inc. This market is expected to expand at a CAGR of 11.5% from 2021 to 2028. Increasing technological advancements and rising adoption of revenue cycle management (RCM) tools by various healthcare providers and others have led to development and upgradation of solutions provided by key players are the major factors driving the market.

The integrated type emerged as the largest segment and accounted for significant revenue share of 69.6% in 2020. Integrated solutions provide a coordinated and streamlined format of a variety of financial activities via a single platform, which results in a uniform process of data collection and analysis. Hence, rising adoption of integrated systems is likely to fuel the growth during the forecast period.

Based on product, the software segment is predicted to account for the largest market share valued at USD 159.9 billion in 2020. The growth of the segment is owing to rising adoption and penetration of software-based solutions in the revenue cycle management sector. On the other hand, the service segment is projected to be the fastest-growing segment over the forecast period, owing to the demand of outsourcing services due to the sudden outbreak of the COVID-19 pandemic.

On the basis of delivery mode, the web-based segment dominated the market with the highest revenue share in 2020. Key factors responsible for the augmenting growth are rising installation of integrated solutions, and enhanced accessibility. On the other hand, the cloud-based segment is expected to witness the fastest CAGR over the forecast period.

North America dominated the market in 2020 with the highest revenue share of 52.6%. Strong healthcare infrastructure, government initiatives boosting adoption of RCM solutions, and rising consolidation between vendors offering RCM solutions are some of the major factors driving the demand of RCM tools and services in this region. On the other hand, Asia Pacific is anticipated to be the fastest-growing region during the forecast period. Fast growing economies like South Korea, Singapore, and Australia are investing in RCM healthcare solutions to improve the billing procedures and claim settlements in rural areas which is expected to surge the growth of the RCM services in the region over the forecast period.

Request a free sample copy or view report summary: Revenue Cycle Management Market Report

Revenue Cycle Management Market Report Highlights

• The market was valued at USD 261.8 Billion in 2020 and is anticipated to witness a CAGR of 11.5% over the forecast period
• The software segment accounted for the largest revenue share valued at USD 159.9 billion in 2020 owing to the growing market penetration of software-based solutions in the RCM sector
• In 2020, integrated segment accounted for the largest revenue share of 69.6% owing to the rising need to improve the efficiency of healthcare systems and curtail healthcare costs
• The web-based delivery mode segment dominated the market in 2020 in terms of revenue share

Revenue Cycle Management (RCM) Market Segmentation

Grand View Research has segmented the global revenue cycle management market based on product, type, delivery mode, end-use, and region:

RCM Product Outlook (Revenue, USD Million, 2016 - 2028)

• Software
• Services

RCM Type Outlook (Revenue, USD Million, 2016 - 2028)

• Integrated
• Standalone

RCM Delivery Mode Outlook (Revenue, USD Million, 2016 - 2028)

• On-premise
• Web-based
• Cloud based

RCM End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Physician Offices
• Hospitals
• Diagnostic Laboratories
• Others

RCM Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • China
  • Japan
  • India
  • Singapore
  • South Korea
  • Australia
• Latin America
  • Mexico
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Revenue Cycle Management (RCM) Market

• The SSI Group, Inc.
• AllScripts Healthcare, LLC
• Experian Health, R1 RCM Inc.
• McKesson Corporation
• athenahealth, Inc.
• Epic Systems Corporation
• NXGN Management, LLC
• CareCloud Corporation
• Quest Diagnostics, Inc.
• R1 RCM Inc.

Access Press Release of Revenue Cycle Management Market @ https://www.grandviewresearch.com/press-release/global-revenue-cycle-management-rcm-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Waterproofing Membranes Market Exhibit a Steady 7.5% CAGR through 2028: Grand View Research Inc.

Waterproofing Membranes Market Growth & Trends

The global waterproofing membranes market size is expected to reach USD 37.18 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.5% from 2021 to 2028. The growing advancement in infrastructure and construction activities, coupled with a rise in demand for wastewater and water management, is expected to drive the market.

Adoption of wastewater techniques for water conservation and reuse is increasing owing to the rising demand for portable water resources across the globe. In addition, increasing government support to promote and adopt a wide array of waste management and water treatment initiatives is expected to boost the demand for the product during the forecast period.

Biomembranes are expected to witness a high adoption trend in the coming future owing to the increasing product demand in green building construction. In addition, government support to replace old buildings with new ones is opening new growth avenues for the construction industry, in turn, adding growth to the overall market.

The market is highly dependent upon the dynamics of the raw material supply chain. Although all types of products including cementitious, bituminous, and polyurethane are used for manufacturing waterproofing membranes, cementitious liquid applied membrane and bituminous sheet membranes are the most commonly used waterproofing membranes in the market.

The industry exhibits several mature players controlling a significant market share. However, increasing competition from a large number of small and local manufacturers from the Asia Pacific region is expected to boost the market competition. The market players put high stress on using sustainable raw materials to ensure an environmentally friendly image to their clients.

Request a free sample copy or view report summary: Waterproofing Membranes Market Report

Waterproofing Membranes Market Report Highlights

• By product, liquid applied membranes are expected to register the fastest revenue-based CAGR from 2021 to 2028 on account of their thermal-reflective properties for any exterior surface application
• Polyurethane liquid applied waterproofing membranes are expected to expand at the fastest revenue-based CAGR of 9.5% during the forecast period owing to seamless finish and easy and fast installation procedure
• The roofing application segment accounted for the largest revenue share of over 31.0% in 2020 owing to its high exposure to changing climatic conditions and leakages across residential, commercial, and industrial buildings
• Asia Pacific is projected to register the fastest CAGR in terms of revenue owing to increasing investment in residential and commercial construction due to rapid industrialization and the growing population
• The majority of the manufacturers have started emphasizing the use of sustainable and corrosive protective raw materials for producing waterproofing membranes to increase their market presence. In addition, growing infrastructure in the developing markets of China, India, and Brazil is adding rapid growth to the construction sector, thereby offering growth prospects to the market

Waterproofing Membranes Market Segmentation

Grand View Research has segmented the global waterproofing membranes market on the basis of product, application, and region:

Waterproofing Membrane Product Outlook (Volume, Million Square Meters; Revenue, USD Million, 2017 - 2028)

• Liquid Applied Membranes
  • Cementitious
  • Bituminous
  • Polyurethane
  • Acrylic
  • Others
• Sheet Membranes
  • Bituminous
  • Polyvinyl Chloride (PVC)
  • Ethylene Propylene Diene Monomer (EPDM)
  • Others

Waterproofing Membrane Application Outlook (Volume, Million Square Meters; Revenue, USD Million, 2017 - 2028)

• Roofing
• Walls
• Building Structures
• Landfills & Tunnels
• Others

Waterproofing Membrane Regional Outlook (Volume, Million Square Meters; Revenue, USD Million, 2017 - 2028)

• North America
  • US.
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • Japan
• Central & South America
  • Brazil
• Middle East & Africa

List of Key Players of Waterproofing Membranes Market

• BASF SE
• Kemper System America, Inc.
• GAF Materials Corporation
• Paul Bauder GmbH & Co. KG
• CICO Technologies Ltd.
• Fosroc Ltd.
• DuPont

Access Press Release of Waterproofing Membranes Market@ https://www.grandviewresearch.com/press-release/waterproofing-membranes-market

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Defibrillator Market Projected to Discern Stable Expansion by 2028

 Defibrillator Market Growth & Trends

The global defibrillator market size is expected to reach USD 22.2 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.4% from 2021 to 2028. Factors contributing to the growth of this market include supportive legislative reforms, rising incidences of sudden cardiac arrests in the region, presence of integrated technology, and rising awareness for cardiac conditions. Moreover, the COVID 19 pandemic further accentuated the need for defibrillators as many elderly patients suffering from COVID-19, suffered from sudden cardiac arrests, and the device was useful for the resuscitation of such patients.

The rising demand for handling sudden cardiac arrests is leading to innovation in implantable as well as external defibrillators. Innovation with regards to implantable devices includes subcutaneous and transvenous devices, that aim to increase the comfort level of patients. Swedish Transport Agency ran a program in 2017 under the test phase, which aimed to deliver AEDs using a drone. This may reduce the delivery time of an AED, increasing the chances of survival with faster treatment. Therefore, the market is anticipated to grow because of technological advancements and product delivery innovations.

Major market players are focused on launching technologically advanced products to enhance their presence. For instance, in July 2020, Zoll Medical Corporation launched a new remote view technology feature on its X Series monitor/defibrillator. This enhanced the existing product portfolio.

Request a free sample copy or view report summary: Defibrillator Market Report

Defibrillator Market Report Highlights

• The implantable cardioverter defibrillator segment dominated the market in terms of revenue share in 2020 and is projected to witness a CAGR of over 7.2% from 2021 to 2028. Technological advancements by market players are expected to drive segment growth
• North America held the largest revenue share in 2020, due to the supportive healthcare infrastructure and deeper penetration of the technologically advanced devices
• The industry participants are focusing on investing in acquisitions, collaborations, product launches, and partnerships to gain a competitive edge
• The hospital segment held the largest revenue share of more than 91.0% in 2020 owing to the high patient footfall for treatment of their cardiovascular ailments
• In Asia Pacific, the market is anticipated to witness a CAGR of around 8.1% owing to the presence of emerging economies such as China and India and increasing healthcare expenditure
• In January 2020, Medtronic received the CE mark for its Crome and Cobalt portfolio of defibrillators. This significantly enhanced the company’s cardiac solutions offerings and allowed it to commercialize the products in the market

Defibrillator Market Segmentation

Grand View Research has segmented the global defibrillator market on the basis of product, end-use, and region:

Defibrillators Product Outlook (Revenue, USD Million, 2016 - 2028)

• Implantable Cardioverter Defibrillator
  • S-ICD
  • T-ICD
    • Single Chamber
    • Dual Chamber
    • CRT-D
  • External Defibrillator
    • Manual ED
    • Automated ED
    • Wearable Cardioverter Defibrillators

Defibrillators End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospital
• Pre Hospital
• Public Access market
• Alternate Care market
• Home Healthcare

Defibrillators Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Defibrillator Market

• Medtronic
• Abbott
• Boston Scientific Corporation
• Stryker
• Koninklijke Philips N.V.
• Zoll Medical Corporation
• Biotronik, Inc.
• Nihon Kohden Corporation
• Progetti Srl, Schiller
• MS Westfalia GmbH
• AMI Italia
• Axion Ltd
• Bexen Cardio

Access Press Release of Defibrillator Market@ https://www.grandviewresearch.com/press-release/global-defibrillators-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Home Infusion Therapy Market Poised to Expand at a Robust Pace Over 2028: Grand View Research Inc.

 Home Infusion Therapy Market Growth & Trends

The global home infusion therapy market size is expected to reach USD 44.7 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.5% from 2021 to 2028. Home infusion therapy involves the intravenous or subcutaneous administration of drugs or biological products to an individual at home. Favorable government policies and regulations are expected to propel market growth. In February 2018, the Bipartisan Budget Act of 2018 was signed into a law that states that all temporary payments of home infusion therapy in the U.S. will be covered by the government in accordance with this regulation.

In addition, the rising prevalence of chronic diseases, such as cardiovascular diseases (CVDs), cancer, diabetes, and other life-threatening conditions, is expected to have a high impact on market growth. According to a report by the WHO, the above-mentioned diseases accounted for 60.0% of the total deaths and 43.0% of the disease burden in the U.S. in 2019. This creates the need to infuse nutritional products that contain glutamine, phospholipids, glucose, and amino acids while administering medication to patients, which, in turn, is expected to boost the market growth.

The ongoing COVID-19 pandemic is expected to create lucrative opportunities for the market. Due to restrictions caused by COVID-19, patients are waiting to seek treatment until they feel safe. Moreover, patients who seek infusion therapy already have diseases that weaken their immune systems. In such cases, going outside even to receive treatment becomes a potential threat. Reduced operating hours have led to difficulty in scheduling appointments as well, even if patients choose to continue treatment. Hence, home infusion therapy is expected to play a key role in supporting patients.

Request a free sample copy or view report summary: Home Infusion Therapy Market Report

Home Infusion Therapy Market Report Highlights

• By product, the infusion pumps segment held the largest revenue share in 2020 owing to the increasing use of delivery fluids, such as nutrients and medications
• The anti-infective application segment dominated the market in 2020 as a large number of procedures are performed during the administration of medications, such as antibiotics and antifungals
• North America dominated the global market in 2020 owing to increasing demand for new technologies, along with advanced healthcare infrastructure
• The Asia Pacific market is projected to witness the fastest growth over the forecast period owing to the increasing number of diabetic patients in the region

Home Infusion Therapy Market Segmentation

Grand View Research has segmented the global home infusion therapy market on the basis of product, application, and region:

Home Infusion Therapy Product Outlook (Revenue, USD Million, 2016 - 2028)

• Infusion Pumps
  • Elastomeric Pumps
  • Electromechanical
  • Gravity
  • Others
• Intravenous Sets
• IV Cannulas
• Needleless Connectors

Home Infusion Therapy Application Outlook (Revenue, USD Million, 2016 - 2028)

• Anti-infective
• Endocrinology
  • Diabetes
  • Others
• Hydration Therapy
  • Athletes
  • Others
• Chemotherapy
• Enteral Nutrition
• Parenteral Nutrition
• Specialty Pharmaceuticals
• Others

Home Infusion Therapy Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Belgium
  • Switzerland
  • Russia
  • Sweden
• Asia Pacific
  • India
  • Japan
  • China
  • Australia
  • South Korea
  • Malaysia
  • Indonesia
  • Singapore
  • Philippines
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Egypt

List of Key Players of Home Infusion Therapy Market

• CVS/Coram
• Option Care Health
• BriovaRx/Diplomat (UnitedHealth Optum)
• PharMerica
• Fresenius Kabi
• ICU Medical, Inc.
• Braun Melsungen AG
• Baxter
• BD
• Caesarea Medical Electronics
• Smiths Medical
• Terumo Corporation
• JMS Co. Ltd.

Access Press Release of Home Infusion Therapy Market@ https://www.grandviewresearch.com/press-release/global-home-infusion-therapy-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Wearable Medical Devices Market to Register Stable Expansion During 2021 – 2028

 Wearable Medical Devices Market Growth & Trends

The global wearable medical devices market size is expected to reach USD 111.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 26.8% from 2021 to 2028. Rising demand for hi-tech products and continuous health monitoring is fueling market growth.

Increasing obesity rate coupled with rising awareness about physical fitness is encouraging people to go for workouts and adopt other fitness-related activities. Wearable devices such as smart bands and smartwatches help in monitoring fitness parameters consisting of calories burned, footstep count, heart rate and distance covered. Moreover, these wearable devices companies offer guidance from experts who are certified dietician or nutrition, and hence, this business model is also generating hefty demand for these ancillary products and services.

Companies such as Google, Fitbit, Apple, and Nike are working towards the launch of new innovative products that are anticipated to boost market growth over the forecast period, thus portraying a high growth rate. Smart watches and wristbands are the current focal point of product development and innovation, leading to abundant availability of such instruments. For instance, HealthPatch, a product of Vital Connect, was launched in March 2014. The product is an adhesive patch that can be placed anywhere on the chest and is used to regulate biometrics such as heart rate, skin temperature, body posture, and activities like steps walked.

The COVID-19 pandemic somehow has a positive impact on the market owing to increasing demand for telemedicine. As per the WHO guidelines people should follow social distancing and avoid public gathering. Hence due to this reason various physicians are preferring telemedicine route so that they can treat patients from distance without spreading the virus. Growth of telemedicine and expansion of applications to Integrate artificial intelligence (AI) in its systems has led to market growth.

Request a free sample copy or view report summary: Wearable Medical Devices Market Report

Wearable Medical Devices Market Report Highlights

• The diagnostic devices segment dominated the market in 2020 owing to the increasing disposable income and awareness, and higher healthcare spending
• The strap/clip/bracelet segment dominated the market in 2020 and is expected to continue its dominance over the forecast period
• Home healthcare held a significant share of 54.0% in 2020 owing to the growing base of geriatric population triggering incidence rates of target diseases
• North America is projected to command for a cumulative share in 2020 due to the increasing application of home care and remote patient monitoring for the purpose of regular, continuous, and long-term monitoring of patients
• Asia Pacific is expected to witness the fastest growth rate over the forecast period. This growth can be attributed to the growing awareness level, increasing disposable income, presence of a large population base and rising incidence rate of chronic conditions

Wearable Medical Devices Market Segmentation

Grand View Research has segmented the global wearable medical devices market based on product, site, application, and region:

Wearable Medical Devices Product Outlook (Revenue, USD Billion, 2016 - 2028)

• Diagnostic Devices
  • Vital Sign Monitoring Devices
    • Heart Rate Monitors
    • Activity Monitors
    • Electrocardiographs
    • Pulse Oximeters
    • Spirometers
    • Blood Pressure Monitors
    • Others
  • Sleep Monitoring Devices
    • Sleep trackers
    • Wrist Actigraphs
    • Polysomnographs
    • Others
  • Electrocardiographs Fetal And Obstetric Devices
  • Neuromonitoring Devices
    • Electroencephalographs
    • Electromyographs
    • Others
  • Therapeutic Devices
    • Pain Management
      • Neurostimulation
      • Others
    • Insulin/Glucose Monitoring
      • Insulin Pumps
      • Others
    • Rehabilitation
      • Accelometers
      • Sensing
      • Ultrasound Platform
      • Others
    • Respiratory Therapy
      • Ventilators
      • Positive Airway Pressure (PAP) Devices
      • Portable Oxygen Concentrators
      • Others

Wearable Medical Devices Site Outlook (Revenue, USD Billion, 2016 - 2028)

• Handheld
• Headband
• Strap/Clip/Bracelet
• Shoe Sensors
• Others

Wearable Medical Devices Application Outlook (Revenue, USD Billion, 2016 - 2028)

• Sports And Fitness
• Remote Patient Monitoring
• Home Healthcare

Wearable Medical Devices Regional Outlook (Revenue, USD Billion, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • France
  • Germany
  • UK.
  • Italy
  • Spain
  • Sweden
  • Russia
  • Netherlands
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Singapore
  • Thailand
  • Philippines
  • Malaysia
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Wearable Medical Devices Market

• Philips Electronics
• Fitbit
• Basis Science
• Garmin
• Covidien
• Omron Corp.
• Withings
• Vital Connect
• Polar Electro
• Intelesens
• Everist Genomics
• Intelesens
• Sotera Wireless

Access Press Release of Wearable Medical Devices Market @ https://www.grandviewresearch.com/press-release/global-wearable-medical-device-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biotechnology Market to Rise at 15.83% CAGR from 2021 to 2028: Grand View Research Inc.

 

Biotechnology Market Growth & Trends

The global biotechnology market size is expected to reach USD 2.44 trillion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 15.83% from 2021 to 2028. The factors driving the market include favorable government policies, the launch of new and advanced products, robust investment in the biotechnology sector, and rising demand for synthetic biology.

Robust funding through alliance investment in start-up biotechnology companies for adopting new and advanced products is contributing to market growth. For instance, in February 2021, Illumina, Inc. invested in nine new genomics companies through Illumina Accelerator in 4 start-ups in the U.K. and 5 start-ups in the U.S. The companies include MultiplAI Health LTD.; BiotaX Labs LTD.; Mitra Bio Limited; Broken String Biosciences Limited; Flightpath Biosciences, Inc.; Doloromics Inc.; Oshun Medical Inc.; Parallel Health Inc.; and Rubik Therapeutics, Inc. Illumina Accelerator is an initiative through which selected startups can access to seed investment, genomics expertise, and Illumina sequencing systems and reagents and seek business guidance.

The bioinformatics application segment is expected to expand at the fastest CAGR from 2021 to 2028 owing to the increasing adoption of these tools for analyzing complex sequencing data. By technology, nanobiotechnology is expected to expand at a lucrative growth rate of 16.8% over the forecast period owing to the growing focus on nanotechnologies for efficient drug delivery and increasing research using this technology.

Supportive government initiatives are significantly contributing to market growth. For instance, in September 2020, the Government of India supported research institutes in agriculture biotechnology, including organic farming. Since the last 3 years, around USD 42.67 million had been invested to support this endeavor.

Moreover, the emergence of the SARS-COV-2 infection is driving the market. Companies are developing new solutions for combating the pandemic situation. For instance, in December 2020, Thermo Fisher Scientific Inc. announced CE-marking for TaqPath COVID-19 that can be used to perform in-vitro diagnosis of SARS-CoV-2, respiratory syncytial virus (RSV) A/B, and influenza A/B infections. The new kit will help in the detection and differentiation between diseases that have similar clinical symptoms.

Request a free sample copy or view report summary: Biotechnology Market Report

Biotechnology Market Report Highlights

• The health application segment accounted for the largest share of 48.64% in 2020 owing to the COVID-19 impact, prevalence of diseases, increasing focus on the development of regenerative medicines, and improving healthcare infrastructure
• The DNA sequencing technology segment held the second-largest share in 2020 owing to its growing penetration in the development of precision medicines
• North America held the largest share of 44.19% in 2020. Companies operating in the region are launching advanced solutions to cater to the needs of the biotechnology industry
• For instance, in February 2021, Waters Corporation launched Waters ACQUITY PREMIER Solution. It is a next-generation liquid chromatography solution for improving analytical data quality
• Asia Pacific is expected to expand at the fastest CAGR of 16.8% from 2021 to 2028 owing to favorable government initiatives and changes in drug approval regulations in India and China

Biotechnology Market Segmentation

Grand View Research has segmented the global biotechnology market on the basis of technology, application, and region:

Biotechnology Technology Outlook (Revenue, USD Billion, 2017 - 2028)

• Nanobiotechnology
• Tissue Engineering And Regeneration
• DNA Sequencing
• Cell-based Assays
• Fermentation
• PCR Technology
• Chromatography
• Others

Biotechnology Application Outlook (Revenue, USD Billion, 2017 - 2028)

• Health
• Food & Agriculture
• Natural Resources & Environment
• Industrial Processing
• Bioinformatics
• Others

Biotechnology Regional Outlook (Revenue, USD Billion, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • France
  • Italy
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Biotechnology Market

• AstraZeneca
• Gilead Sciences, Inc.  
• CELGENE CORPORATION
• Biogen
• Abbott
• Amgen Inc.
• Novo Nordisk A/S
• Merck & Co.
• Johnson & Johnson Services, Inc.
• Novartis AG
• Sanofi
• Hoffmann-La Roche Ltd.
• Pfizer, Inc.
• Lonza

Access Press Release of Biotechnology Market@ https://www.grandviewresearch.com/press-release/global-biotechnology-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.